Donate Now

We need EUR 800,000 to include ME/CFS patients in a promising drug research project.

Donate

100% will go to the University of Erlangen for the establishment of a study "BC007 in ME/CFS".

Information

There are about 300,000 ME/CFS sufferers in Germany who are currently without help.

Donation target

Conducting a study with the drug BC007 for ME/CFS sufferers.

BC007

A drug that has already led to success in long-covid patients

WE NEED 800 000 €

for a medical study at the University Hospital Erlangen with the drug BC007 of the company "Berlin Cures" for ME/CFS patients

ME/CFS (Myalgic Encephalomyelitis / Chronic Fatigue Syndrome) is a serious multi-system disease with devastating effects on the lives of those affected. Symptoms range from complete exhaustion, inability to sit or stand, disorders of the blood circulation regulation, palpitations, strong head, muscle, tendon and nerve pain, dizziness, tinnitus, intermittent paralysis, seizures, burning sensation on the skin, visual and hearing disorders up to to irritation and sensitivity to light, severe concentration disorders and much more. Symptoms gradually worsen with exertion. Affected people can no longer participate in public life and become care cases. ME/CFS can reach a stage where people can no longer speak or eat.

Although classified as neuro-immunological by the WHO in 1969, this serious disease has remained without support, clinical research and treatment to this day. In Germany there are around 300,000 people affected, 40,000 of whom are children and young people. Worldwide there are an estimated 17 million!

Long-Covid, the disease that occurs in around 10% of those infected after infection with the SARS-CoV-2 virus, has resulted in thousands upon thousands developing the full picture of ME/CFS since the beginning of the pandemic.

In mid-September 2021, the German Federal Ministry of Education and Research (BMBF) launched a study to research the drug BC 007 under the direction of Dr. Dr. med. Bettina Hohberger at the University Hospital Erlangen, but ONLY for patients affected by Long-Covid. Unfortunately, this means that ME/CFS patients who have been seriously ill for years and decades for a cure cannot be included in the study despite the large overlap between the two clinical pictures.

 

We want to change that! Miss Dr. Hohberger would also like to help those affected and set up a parallel study for ME/CFS.


For this we need 800,000 EUR

THEREFORE this campaign!

 

It is a chance for ME/CFS sufferers not only to become publicly visible, but finally to take part in a drug study that could improve their living situation, possibly even lead to a cure!

Please help us to make this study possible for ME/CFS patients!

Donate by bank transfer,
with PayPal or Credit Card

Your money goes directly to our donation account at Berliner Sparkasse: 

 

Brückeverbindet e.V.
IBAN: DE43 1005 0000 0191 0769 61
BIC: BELADEBEXXX 

 

In case of direct bank transfer please use the


Kennwort “BC007 für ME/CFS”.

 

If the donation exceeds 200 €, please also include your e-mail and postal address for sending the donation receipt in the payment reference.

 

GiroCode

PayPal or credit card

Wegen der hohen Gebühren bei PayPal bitten wir Sie bevorzugt per Banküberweisung zu spenden. Vielen Dank!

QR-Code links to PayPal

Donation barometer

donations received
125 EUR
Current:
Target:

The non-profit association Brückeverbindet e.V. collects the donations for this project on a specially set up account. Your donation goes 100% to the research project of the UNI-Erlangen to include ME/CFS sufferers in the study with the promising drug BC007.

en_GBEnglish